Sec. 503. Research Policy Board reauthorization
136 words·~1 min read·
/bill/117/hr/6000/ih/section-503·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 2034(f)(6) of the 21st Century Cures Act ( 42 U.S.C. 3501 note) is amended by striking September 30, 2021 and inserting September 30, 2026 . Section 2034(f)(2)(A) of the 21st Century Cures Act ( 42 U.S.C. 3501 note) is amended— by redesignating clause
(v)as clause (vi); by inserting after clause
(iv)the following: The Director of the National Institutes of Health. . Section 2034(f)(2) of the 21st Century Cures Act ( 42 U.S.C. 3501 note) is amended by adding at the end the following: Notwithstanding any other provision of law, the Director of the National Institutes of Health may participate in the activities of the Board, including the formulation of recommendations, without regard to limitations relating to indirect costs in part 75 of title 45, Code of Federal Regulations (or any successor regulations). .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 503
Research Policy Board reauthorization
Cites 1Cited by 0 across 0 sources